Fit For Your Company:
UnknownEnter your company details to see if Mary Szela is a good fit as an investor for your company.
Enter Your CompanyMary Szela
CEO and President at Novelion Therapeutics
Chicago, United States
Invests in Biotechnology, Biopharma, Therapeutics
Seed, Early, Growth, Pre-Seed, Series A
Upgrade to Funden Lite to see Mary Szela's email address